Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks

Lifebit’s Natural Language Processing and Artificial Intelligence platform automatically detects and tracks global infectious disease outbreaks using real-world evidence The captured insights can accelerate detection of the latest outbreaks including transboundary diseases and emerging pathogens London, United Kingdom, June 9, 2021 – Lifebit Biotech Ltd announces the beginning of a long-term partnership with Boehringer Ingelheim to utilise Natural Language Processing...

Lifebit joins the Alliance for Artificial Intelligence in Healthcare (AAIH)

We are excited to announce that Lifebit is officially part of the Alliance for Artificial Intelligence in Healthcare (AAIH), where we will work alongside a number of industry leaders to support the advancement of AI in healthcare. What is the Alliance for Artificial Intelligence in Healthcare? AAIH represents a coordinated, global effort across the healthcare, life science and technology industries...

Lifebit Awarded A Four-Year Contract for Hong Kong’s Genome Project

Lifebit’s precision medicine software will power Hong Kong’s development of genomic medicine by supporting the Hong Kong Genome Institute to implement the first large-scale genome sequencing initiative, the Hong Kong Genome Project. The Project will empower medical professionals and researchers to leverage up to 50,000 whole genomes to achieve faster diagnosis, develop more precise and personalised treatments and perform disease...

Lifebit has been selected by EHDEN to pave the way for an acceleration in mapping health data

Lifebit has been selected by the European Health Data & Evidence Network (EHDEN) for the recent Open Call, paving the way for an acceleration in mapping health data from various formats and institutions to the OMOP Common Data Model (CDM).  As part of the EHDEN network, Lifebit will support a diverse ecosystem of European institutions in performing mappings and harmonising...

Lifebit CEO Dr Maria Chatzou Dunford at the AWS Startup Industry Days 2021 – Healthcare and Life Sciences

Amazon Web Services (AWS) recently hosted AWS Startup Industry Days focused on Healthcare and Life Sciences. The two-day virtual event gathered thought leaders across Healthcare and Lifebit Sciences – and our CEO Dr Maria Chatzou Dunford was featured as a speaker.  In the session, Dr Chatzou Dunford along with Patrick Lamplé, AWS Senior Specialist Solutions Architect for Healthcare and Life...

The next great leap in drug development will come from clinico-genomics data – But do we have the right approach?

As genomic, phenotypic and clinical data are continuously being generated at an exponential pace, the biopharma industry must find more efficient ways of accessing and working with large volumes of complex and siloed data. This is especially critical for big pharmaceutical companies that need to optimise and accelerate clinical research and drug development processes. In a recent interview with Pharma...

Recap of PopGen:Live – Behind-the-scenes of Genomics England’s revolutionary new Research Environment

National initiatives and biobanks have been driving the genomics transformation for years – however these efforts have been fraught with major challenges as biomedical data grows exponentially, including usability, commercial and security challenges. However, the greatest challenge faced by these initiatives is the fact that data is becoming more siloed and distributed than ever before.   Lifebit has launched a new...